Related Experiment Video
Updated: Aug 8, 2026

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Microglial signaling by amyloid beta protein through mitogen-activated protein kinase mediating phosphorylation of
H Hasegawa1, M Nakai, S Tanimukai
1Hyogo Institute for Aging Brain and Cognitive Disorders, 520 Saisho-ko, Himeji 670-0981, Japan.
Abstract:
Myristoylated alanine-rich C kinase substrate (MARCKS), an acidic protein associated with cell motility and phagocytosis, is activated upon phosphorylation by protein kinase C (PKC) and proline-directed protein kinases. In Alzheimer disease (AD), activated microglia expressing MARCKS migrates around senile plaques. We reported that amyloid beta protein (A beta), a major component of senile plaques, activated MARCKS through a tyrosine kinase and PKC-delta. We have now identified another A beta signaling pathway through a mitogen-activated protein kinase (MAPK) involved in the phosphorylation of MARCKS and analysed cross-talk between PKC and MAPK pathways in primary cultured rat microglia. A selective inhibitor for MAPK kinase, PD098059, significantly inhibited the phosphorylation of MARCKS induced by A beta. Extracellulary regulated kinases, the activities of which were induced by A beta, directly phosphorylated a recombinant MARCKS in vitro. The MAPK pathway was sensitive to wortmannin, but not to a PKC inhibitor or to tyrosine kinase inhibitors. The activation of PKC by A beta was not sensitive to wortmannin. Our findings suggest involvement of the MAPK pathway through phosphoinositol 3-kinase in the phosphorylation of MARCKS in rat cultured microglia, an event may be associated with mechanisms activating microglia in AD.
Insights
Amyloid beta activates microglia in Alzheimer disease by phosphorylating MARCKS protein via both PKC and MAPK pathways. This study identifies the mitogen-activated protein kinase pathway as a key player in MARCKS activation.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Myristoylated alanine-rich C kinase substrate (MARCKS) is crucial for cell motility and phagocytosis.
- MARCKS activation is implicated in Alzheimer disease (AD) pathogenesis, particularly in microglia surrounding amyloid plaques.
- Previous work identified amyloid beta (Aβ) activating MARCKS via tyrosine kinase and PKC-delta.
Purpose of the Study:
- To investigate the role of mitogen-activated protein kinase (MAPK) signaling in Aβ-induced MARCKS phosphorylation in microglia.
- To analyze the cross-talk between protein kinase C (PKC) and MAPK pathways in response to Aβ.
- To elucidate the specific kinases involved in Aβ-mediated MARCKS activation in rat microglia.
Main Methods:
- Primary cultured rat microglia were treated with amyloid beta (Aβ).
- The effect of MAPK kinase inhibitor PD098059 on Aβ-induced MARCKS phosphorylation was assessed.
- In vitro phosphorylation assays using recombinant MARCKS and extracellularly regulated kinases (ERK) were performed.
- Sensitivity of MAPK and PKC pathways to wortmannin and specific inhibitors was analyzed.
Main Results:
- A selective MAPK kinase inhibitor (PD098059) significantly reduced Aβ-induced MARCKS phosphorylation.
- Aβ induced extracellularly regulated kinases (ERK) activity, which directly phosphorylated MARCKS in vitro.
- The MAPK pathway was sensitive to wortmannin, while Aβ-induced PKC activation was not.
- PKC and MAPK pathways showed differential sensitivity to inhibitors, suggesting distinct signaling.
Conclusions:
- The mitogen-activated protein kinase (MAPK) pathway, potentially involving phosphoinositol 3-kinase, plays a significant role in Aβ-induced MARCKS phosphorylation in microglia.
- This MAPK-mediated phosphorylation of MARCKS may contribute to microglial activation mechanisms in Alzheimer disease.
- Distinct signaling pathways are involved in Aβ-induced activation of PKC and MAPK.
More Related Videos
Related Concept Videos
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
MAPK Signaling Cascades
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Intracellular Signaling Affects Focal Adhesions
Some...

